TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2012

State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Alabama 268 42.5 6.2 (30.3 – 54.7) 271 42.7 6.3 (30.4 – 55.0)
Arizona 222 34.4 6.6 (21.5 – 47.3) 229 25.4 6.7 (12.3 – 38.5)
California 316 39.0 4.5 (30.2 – 47.8) 336 36.9 4.3 (28.5 – 45.3)
Connecticut 241 43.3 5.6 (32.3 – 54.3) 249 42.3 5.9 (30.7 – 53.9)
District of Columbia 98 32.7 8.8 (15.5 – 49.9) 106 37.9 10.4 (17.5 – 58.3)
Florida 215 41.4 8.5 (24.7 – 58.1) 230 43.1 8.2 (27.0 – 59.2)
Georgia 142 32.0 7.2 (17.9 – 46.1) 160 29.7 6.6 (16.8 – 42.6)
Hawaii 143 29.7 6.6 (16.8 – 42.6) 152 38.6 6.3 (26.3 – 50.9)
Illinois 205 32.0 5.3 (21.6 – 42.4) 219 28.4 5.0 (18.6 – 38.2)
Indiana 238 28.5 4.5 (19.7 – 37.3) 260 25.1 4.1 (17.1 – 33.1)
Iowa 197 24.4 4.3 (16.0 – 32.8) 201 25.0 4.3 (16.6 – 33.4)
Kansas 388 34.3 4.4 (25.7 – 42.9) 402 34.7 4.3 (26.3 – 43.1)
Louisiana 261 30.2 5.8 (18.8 – 41.6) 274 26.3 5.3 (15.9 – 36.7)
Maine 216 45.3 5.8 (33.9 – 56.7) 228 44.7 5.5 (33.9 – 55.5)
Massachusetts 198 34.5 5.7 (23.3 – 45.7) 232 31.1 5.0 (21.3 – 40.9)
Michigan 448 35.8 3.7 (28.5 – 43.1) 488 34.7 3.6 (27.6 – 41.8)
Mississippi 261 20.7 3.5 (13.8 – 27.6) 261 20.9 3.5 (14.0 – 27.8)
Missouri 227 37.0 6.1 (25.0 – 49.0) 240 33.5 5.8 (22.1 – 44.9)
Montana 277 39.6 6.0 (27.8 – 51.4) 289 37.9 6.0 (26.1 – 49.7)
Nebraska 508 35.0 4.0 (27.2 – 42.8) 523 34.2 3.9 (26.6 – 41.8)
Nevada 142 20.7 4.9 (11.1 – 30.3) 158 19.0 4.4 (10.4 – 27.6)
New Hampshire 264 29.3 3.9 (21.7 – 36.9) 281 29.5 3.7 (22.2 – 36.8)
New Jersey 385 25.6 3.8 (18.2 – 33.0) 409 25.5 3.6 (18.4 – 32.6)
New Mexico 292 44.3 5.0 (34.5 – 54.1) 307 41.8 4.8 (32.4 – 51.2)
New York 173 29.2 5.9 (17.6 – 40.8) 189 30.2 5.8 (18.8 – 41.6)
North Carolina 155 37.8 8.2 (21.7 – 53.9) 174 32.8 7.5 (18.1 – 47.5)
North Dakota 150 30.1 5.3 (19.7 – 40.5) 149 28.6 5.2 (18.4 – 38.8)
Ohio 393 30.2 3.9 (22.6 – 37.8) 416 27.2 3.8 (19.8 – 34.6)
Oklahoma 210 33.8 6.8 (20.5 – 47.1) 216 29.2 6.5 (16.5 – 41.9)
Oregon 198 26.9 4.3 (18.5 – 35.3) 220 25.3 3.9 (17.7 – 32.9)
Pennsylvania 577 38.7 4.4 (30.1 – 47.3) 617 37.0 4.2 (28.8 – 45.2)
Rhode Island 187 45.9 6.3 (33.6 – 58.2) 190 42.1 6.2 (29.9 – 54.3)
Texas 212 36.8 8.5 (20.1 – 53.5) 220 32.9 8.1 (17.0 – 48.8)
Vermont 234 33.0 4.6 (24.0 – 42.0) 244 31.4 4.3 (23.0 – 39.8)
Washington 463 39.6 4.3 (31.2 – 48.0) 487 39.2 4.0 (31.4 – 47.0)
West Virginia 211 30.2 3.9 (22.6 – 37.8) 212 31.1 3.9 (23.5 – 38.7)
Wisconsin 181 46.4 8.2 (30.3 – 62.5) 185 47.3 8.2 (31.2 – 63.4)
37 state total 9,496 35.2 1.4 (32.5 – 37.9) 10,024 33.2 1.4 (30.5 – 35.9)
Median   34.3       32.8    
Range   20.7-46.4       19.0-47.3    

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Landline sample size excludes “DK/Refused”

§ Standard error

Confidence interval